기본 콘텐츠로 건너뛰기

PAWZ (ProShares Pet Care ETF) — The Only U.S. ETF for Investors Who Love Pets

Around the world, pets are no longer seen as mere companions — they are embraced as full-fledged members of the family. As single-person households and aging populations increase, pet adoption is on the rise, and with it, the pet care industry is experiencing robust expansion.

As of 2025, the global pet care market is estimated at $324 billion, and it's projected to reach nearly $598 billion by 2033, growing at an average annual rate of 7.3%.

So, how can investors tap into the growth of this booming industry? Today’s featured ETF is the ProShares Pet Care ETF (PAWZ) — a fund that invests across a diverse portfolio of companies in pet healthcare, retail, nutrition, insurance, and more.

* ETF Overview

  • Name: ProShares Pet Care ETF
  • Ticker: PAWZ
  • Assets Under Management (AUM): $62.6M (₩85.1B as of 2025/6/11)
  • NAV (Net Asset Value): $58.46 (as of 2025/6/11)
  • Daily Trading Volume: 2,963 shares
  • Expense Ratio: 0.50%

* Investment Strategy

  • PAWZ is the only ETF in the U.S. market dedicated entirely to the pet care industry.
  • Other ETFs may include pet-related companies within broader consumer or healthcare sectors, but PAWZ focuses exclusively on pets.
  • It tracks the FactSet Pet Care Index, targeting businesses involved in veterinary care, pet food and supplies, insurance, diagnostics, and distribution.
  • Companies span across multiple countries — including the U.S., U.K., Canada, and Europe — and industries such as healthcare, consumer goods, and financial services.
  • The portfolio is growth-oriented, composed mostly of small- and mid-cap companies, resulting in higher volatility but greater upside potential.

* Top 10 Holdings

Company Ticker Sector Business Description Weight
Chewy Inc - Class A CHWY Consumer Online retailer of pet food, toys, treats 10.80%
IDEXX Laboratories Inc IDXX Healthcare Veterinary diagnostic tools & software 9.98%
Zoetis Inc ZTS Healthcare Animal antibiotics, vaccines,
pain relievers		 9.79%
Freshpet Inc FRPT Consumer Refrigerated premium pet food 9.15%
Pets at Home Group PLC PETS.L Consumer Pet retail, vet clinics & grooming (U.K.) 7.03%
Trupanion Inc TRUP Financial Pet health insurance plans & platforms 4.94%
Vimian Group AB VIMIAN.ST Healthcare Veterinary pharmaceuticals & diagnostics 4.72%
Pet Valu Holdings Ltd PET.TO Consumer Pet supplies retailer (Canada) 4.52%
Virbac SA VIRP.PA Healthcare Pet vaccines, antiparasitics & antibiotics 4.51%
Merck & Co. Inc MRK Healthcare Animal health products via Merck Animal Health 4.50%

* Conclusion: Why Choose PAWZ?

Rather than chasing short-term trends, PAWZ is designed for long-term investors who believe in the structural shift toward a pet-centric society. If you see value in the emotional bond between people and their animals — and believe that this sentiment will continue fueling consumption — PAWZ may be the ideal ETF to align your values and your portfolio.

라벨:

댓글

댓글 쓰기

이 블로그의 인기 게시물

Why Did HIMS Stock Crash? A Deep Dive into Digital Healthcare Risks

The digital healthcare industry is growing rapidly, but it comes with significant risks. Recently, U.S.-based telehealth company Hims & Hers Health (HIMS) experienced a sharp stock drop, raising red flags for investors. This post explores HIMS’s business model, recent developments, and future outlook. What is Hims & Hers Health (HIMS)   Hims & Hers Health Inc. is a U.S. digital healthcare company offering a wide range of online health solutions( Hair loss treatment, Skin care, Sexual health, Mental health, Wellness (e.g., sleep aids, vitamins, weight management) ) . Through its platform, users complete a brief questionnaire via website or mobile app, which is reviewed by licensed professionals. If approved, prescriptions are delivered to the customer’s home. Some products are also available over-the-counter.  Why Is HIMS Popular?   HIMS operates on a Direct-to-Consumer (D2C) model , with most products offered via monthly subscriptions . This approach...
댓글 쓰기
자세한 내용 보기

📊 Comparing 3 China Tech ETFs: DRAG vs. TIGER China Tech Top10 vs. KODEX China Tech Top10 — Which Strategy Fits You?

With valuations for Chinese tech stocks still appearing attractive, I explored three ETFs that take different strategic approaches to China's growth potential. Previously, I introduced the U.S.-listed DRAG ETF, and recently, Mirae Asset’s TIGER China Tech Top10 and Samsung Asset Management’s KODEX China Tech Top10 were listed on the Korean exchange. All three focus on concentrated portfolios of selected large-cap Chinese tech stocks—but their investment strategies differ significantly , and that’s what I want to highlight. The previous post is linked below ⬇️ China Stock Market Valuation   DRAG ETF : China Tech Leader ETF 1️⃣ Roundhill China Dragons ETF (DRAG) U.S.-listed | Focused investment in select Chinese tech giants AUM : $30.06M (₩41.3B approx., as of June 19, 2025) NAV : $25.01 Volume : 2,293 shares (as of June 12, 2025) Expense Ratio : 0.59% No. of Holdings : 6 Strategy : Active Top Holdings : Tencent, Alibaba, Xiaomi, BYD, Pinduoduo, Meituan 🔎 Key Features ...
댓글 쓰기
자세한 내용 보기

Analysis of U.S. Healthcare Trends: Which Sectors Are Thriving?

 The U.S. healthcare industry is evolving rapidly, influenced by policy changes and technological innovation. The restructuring of healthcare under the Trump administration, along with the expansion of Health Services & Technology (HST) and Specialty Pharmacies , are key developments shaping the market. 1. Overview of the U.S. Healthcare System Unlike South Korea, the U.S. does not have a universal national health insurance system . Instead, it operates on a private insurance-driven healthcare model. Healthcare costs in the U.S. are among the highest in the world, and without insurance, patients face exorbitant medical expenses. As a result, private health insurance is essential, and many companies offer employee benefits that include health coverage. This has led to a highly competitive and active private insurance market . As of 2023, 17.6% of the U.S. population is aged 65 or older , and the average life expectancy is 79.3 years . Meanwhile, the mortality rate has decli...
댓글 쓰기
자세한 내용 보기